Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors |
1.75 |
08/09/2023 - 12:00am to 08/09/2024 - 12:00am |
NCCN Guidelines® Insights - Survivorship, Version 1.2023 |
1.00 |
08/10/2023 - 12:00am to 08/10/2024 - 12:00am |
Acute Myeloid Leukemia Patient Management Simulator |
|
08/10/2023 - 12:00am to 08/09/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Treatment of Deficient Mismatch Repair or Microsatellite Instability-High (dMMR/MSI-H) Colorectal Cancer |
1.00 |
08/18/2023 - 12:00am to 08/18/2024 - 12:00am |
Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia |
1.00 |
08/23/2023 - 12:00am to 08/23/2024 - 12:00am |
NCCN Guidelines® Insights - Breast Cancer Screening and Diagnosis, Version 1.2023 |
1.00 |
09/10/2023 - 12:00am to 09/10/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Ampullary Adenocarcinoma: Overview of Subtypes and Treatments |
1.00 |
09/21/2023 - 12:00am to 09/13/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Thyroid Carcinomas |
1.00 |
10/02/2023 - 12:00am to 10/02/2024 - 12:00am |
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 |
1.00 |
10/10/2023 - 12:00am to 10/10/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell... |
1.00 |
10/26/2023 - 12:00am to 10/26/2024 - 12:00am |
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 6.2023 |
1.00 |
11/10/2023 - 12:00am to 11/10/2024 - 12:00am |
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™ |
|
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Revolutionizing Hematologic Cancer Treatment: The Promise of Bispecific T-Cell Engagers |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Adult Acute Lymphocytic Leukemia: Strategies for Selection of Consolidation Therapy |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |